The invention provides compounds of formula (I) wherein: T is C(O) or S(O).sub.2; W is C(O) or S(O).sub.2; X is CH.sub.2, O or NH; Y is CR.sub.11 or N; n is 0, 1 or 2; m is 1 or, when Y is CR.sub.11 m is 0; R.sub.1 is optionally substituted aryl or optionally substituted heterocyclyl; R.sub.2, R.sub.3, R,.sub.4, R.sub.5, R.sub.6, R.sub.7 and R.sub.8 are, independently, hydrogen or C?1-6#191 alkyl; R.sub.9 is hydrogen or C.sub.1-C.sub.6 alkyl; R.sub.10 is alkyl, optionally substituted aryl, optionally substituted aralkyl or optionally substituted heterocyclyl; and R.sub.11 is hydrogen or C.sub.1-C.sub.6 allkyl; that are modulators of chemokine (especially CCR3) activity and are especially useful for treating asthma and/or rhinitis.